³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2023-2030³â)
Geriatric Care Services Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
»óǰÄÚµå
:
1457343
¸®¼Ä¡»ç
:
Persistence Market Research
¹ßÇàÀÏ
:
2024³â 02¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 216 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¼¼°è ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå¿¡ ´ëÇÑ ½ÉÃþ ºÐ¼®À» ¹ßÇ¥ÇÏ¿© ÁÖ¿ä ½ÃÀå ¿ªÇÐ, ¼ºÀå ÃËÁø¿äÀÎ ¹× °úÁ¦, ½ÅÈï µ¿Çâ¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ °³¿ä¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ º¸°í¼´Â ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇϰí 2023-2030³â±îÁöÀÇ ½ÃÀå ¼ºÀå ±ËÀûÀ» ¿¹ÃøÇÏ´Â µ¶Á¡ÀûÀÎ µ¥ÀÌÅÍ¿Í Åë°è¸¦ Á¦½ÃÇÕ´Ï´Ù.
¼¼°è ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå ±Ô¸ð´Â 2023³â 8¾ï 70¸¸ ´Þ·¯¿¡ ´ÞÇϰí, ¿¬Æò±Õ 5.7%ÀÇ ²ÙÁØÇÑ ¼ºÀå¼¼¸¦ º¸À̸ç 2030³â ¸»¿¡´Â 5¾ï 4,320¸¸ ´Þ·¯·Î ±ÞÁõÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå ±Ô¸ð(2023E) : 8¾ï 70¸¸ ´Þ·¯
¿¹»ó ½ÃÀå ±Ô¸ð(2030F) : 5¾ï 4,320¸¸ ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(2023-2030³â CAGR) : 5.7%
°ú°Å ½ÃÀå ¼ºÀå·ü(2018-2022³â CAGR) : 5.3%
³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå - Á¶»ç ¹üÀ§
³ëÀÎÀÇÇÐ(³ëÀκ´ÇÐ)Àº ³ëÈ¿Í °ü·ÃµÈ °Ç° ¹®Á¦¸¦ ÇØ°áÇÔÀ¸·Î½á ³ëÀÎÀÇ ÇູÀ» ÁõÁø½ÃŰ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. ³ëÀÎÀÇÇÐÀº °¡Á¤, º´¿ø, ¿ä¾ç¿ø µî ´Ù¾çÇÑ È¯°æ¿¡¼ Á¦°øµÇ´Â ÀÇ·á ¹× ºñÀÇ·á ¼ºñ½º¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ¹°¸®Ä¡·á, ¼ö¾× ¿ä¹ý µîÀÌ ÀÖ½À´Ï´Ù. ³ëÀÎ ÀÇ·á ¼ºñ½º ½ÃÀåÀº ÇコÄÉ¾î ºÐ¾ßÀÇ ¼ºñ½º °³¼±¿¡ ÃÊÁ¡À» ¸ÂÃá R&D ÅõÀÚ Áõ°¡¿Í À¯¸®ÇÑ »óȯ Á¤Ã¥À¸·Î ÀÎÇØ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:
Àü ¼¼°èÀûÀ¸·Î ³ëÀÎ Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¾ËÃ÷ÇÏÀ̸Ӻ´°ú Ä¡¸ÅÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼÷·ÃµÈ °£º´ ¼ºñ½º¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é Àü ¼¼°èÀûÀ¸·Î ¾à 4,750¸¸ ¸íÀÌ Ä¡¸Å¸¦ ¾Î°í ÀÖÀ¸¸ç, ¸Å³â 770¸¸ ¸íÀÌ »õ·Ó°Ô Ä¡¸Å¸¦ ¾Î°í ÀÖ´Â °ÍÀ¸·Î º¸°íµÇ°í ÀÖ½À´Ï´Ù. ¿¬±¸¿¡ µû¸£¸é ´ç´¢º´, ³úÁ¹Áß, °íÇ÷¾Ð°ú °°Àº »ýȰ½À°üº´ÀÌ ¾ËÃ÷ÇÏÀ̸Ӻ´ ¹ßº´·ü »ó½Â¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó ¼÷·ÃµÈ °£È£ ¼ºñ½º ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. WHOÀÇ ¿¹Ãø¿¡ µû¸£¸é, 2050³â±îÁö 65¼¼ ÀÌ»ó Àα¸´Â ƯÈ÷ °³¹ßµµ»ó±¹¿¡¼ °ÅÀÇ ¼¼ ¹è·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ³ôÀº ºñ¿ë°ú Á¦ÇÑµÈ ¼ö¿ë¼ºÀÌ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àα¸ Åë°èÇÐÀû º¯È´Â ³ëÀÎ ÄÉ¾î ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ±Ã±ØÀûÀ¸·Î ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ÃÀå ¾ïÁ¦¿äÀÎ:
³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀåÀÇ ¼ºÀåÀº Å« µµÀü¿¡ Á÷¸éÇØ ÀÖÀ¸¸ç, ƯÈ÷ Áö¹æÀÇ ³ëÀÎ ÀÇ·á ¼¾ÅÍ ºÎÁ·ÀÌ Å« ¹®Á¦ÀÔ´Ï´Ù. ³óÃÌ Áö¿ªÀÇ ³ëÀεéÀº »çȸ°æÁ¦Àû °ÝÂ÷¿Í Àü¹® ½Ã¼³ÀÇ ºÎÀç·Î ÀÎÇØ ÇÊ¿äÇÑ ÀÇ·á ¼ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Á¦ÇѵǾî ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´Ù¾çÇÑ ÀÇ·á ºÐ¾ßÀÇ Àη ºÎÁ·°ú ÀÇ·áºñ Áõ°¡°¡ ½Ã±ÞÇÑ Àå¾Ö¹°·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÚ°ÝÀ» °®Ãá Àü¹®°¡ ºÎÁ·°ú °æÁ¦Àû À庮Àº ÇʼöÀûÀÎ ³ëÀÎ ÄÉ¾î ¼ºñ½º¿¡ ´ëÇÑ Á¢±ÙÀ» ¹æÇØÇϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ Á¦¾àÀ» ÇØ°áÇÏ°í ¸ðµç ³ëÀÎÀÌ °øÆòÇÏ°Ô Äɾ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï Çϱâ À§ÇÑ Àü·«Àû °³ÀÔÀÇ Çʿ伺À» °Á¶Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ±âȸ:
³ëÀÎ Äɾ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ Àü ¼¼°è ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå¿¡ Å« ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù ÇコÄÉ¾î °ü¸®ÀÇ º¯È¿Í ³ëÀÎÀÇ ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡´Â ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. °¢±¹ Á¤ºÎ´Â °í·ÉÈ »çȸÀÇ »îÀÇ Áú Çâ»ó¿¡ Àû±ØÀûÀ¸·Î ³ª¼°í ÀÖÀ¸¸ç, ÀÌ´Â Àü¹®ÀûÀÎ ³ëÀÎ ÄÉ¾î ¼ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á º¸»ó Á¤Ã¥ÀÇ °³¼±°ú ´õ ³ôÀº Ä¡·á ±âÁØÀÇ È®¸³À» À§ÇÑ ³ë·ÂÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÇコÄɾ ´ëÇÑ ÅõÀÚ È®´ë°¡ ¿¹»óµÊ¿¡ µû¶ó ¼¼°è ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀåÀÇ ¼öÀÍÀÌ Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º» º¸°í¼¿¡¼ ´Ù·ç´Â ÁÖ¿ä Áú¹®µé
³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
³ëÀÎ ÄÉ¾î ¼ºñ½º ¼ö¿ä¸¦ ÁÖµµÇÏ´Â »ê¾÷Àº?
±â¼úÀÇ ¹ßÀüÀº ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀåÀÇ °æÀï ±¸µµ¸¦ ¾î¶»°Ô º¯È½Ã۰í Àִ°¡?
¼¼°è ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?
¼¼°è ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå¿Í ÇâÈÄ Àü¸ÁÀº?
°æÀï»ç Á¤º¸ ¹× ºñÁî´Ï½º Àü·«:
Endo Pharmaceuticals Inc., Merck & Co., AstraZeneca PLC¿Í °°Àº ´ë±â¾÷µéÀº ±â¼ú Àü¹® Áö½Ä°ú ÇコÄÉ¾î »ê¾÷¿¡¼ÀÇ Ç³ºÎÇÑ °æÇèÀ» ¹ÙÅÁÀ¸·Î ³ëÀÎ ÄÉ¾î ºÐ¾ßÀÇ Çõ½ÅÀ» ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ³ëÀο¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̰í ÀÔ¿øÀ» ÁÙÀ̱â À§ÇÑ ³ë·ÂÀÌ È®»êµÇ°í ÀÖ½À´Ï´Ù. °¢ ±â¾÷Àº ±â¼ú ¹ßÀü, Àü·«Àû ÆÄÆ®³Ê½Ê, »ç¿ëÀÚ °æÇè °³¼±¿¡ ¿ì¼±¼øÀ§¸¦ µÎ°í ÀÖ½À´Ï´Ù. ½ÃÀå °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ Çõ½ÅÀûÀÎ ±â´É, °³ÀÎÈµÈ ¼ºñ½º, ºÎ°¡°¡Ä¡ Á¦°øÀ» ÅëÇÑ Â÷º°È¸¦ °Á¶Çϰí, Çù¾÷ ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÅëÇØ »õ·Î¿î ½ÃÀåÀ¸·Î È®ÀåÇÏ´Â °ÍÀÌ Áß¿äÇÑ ÃÊÁ¡ÀÌ µÇ°í ÀÖ½À´Ï´Ù.
ÁÖ¿ä ȸ»ç ÇÁ·ÎÇÊ:
Endo Pharmaceuticals Inc.
Merck & Co.
AstraZeneca PLC
Pfizer Inc.
Allergan Inc.
Bristol-Myers Squibb Company
Regeneron Pharmaceuticals Inc.
AstraZeneca PLC
F. Hoffmann-La Roche AG
Octapharma AG
Epoch Elder Care
St Luke's ElderCare Ltd.
³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå ¼¼ºÐÈ:
¼ºñ½ºº°
ÀçÅà ³ëÀÎ ÄÉ¾î ¼ºñ½º
¼ºÀÎ ³ëÀÎ µ¥ÀÌÄÉ¾î ¼ºñ½º
½Ã¼³ ³ëÀÎ ÄÉ¾î ¼ºñ½º
ÁöºÒ¿øº°:
°ø°ø º¸ÇèÀ¸·Î Áö±Þ
¹Î°£ º¸ÇèÀ¸·Î ÁöºÒ
º»Àκδã±Ý
±âŸ ÁöºÒ
¿ëµµº°
È£Èí±âÁúȯ
´ç´¢º´
½ÉÀåÁúȯ
½Å°æÁúȯ
½ÅÀåÁúȯ
¾Ï
±âŸ
Áö¿ªº°
ºÏ¹Ì
À¯·´
µ¿¾Æ½Ã¾Æ
³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾Æ
¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀå ¹üÀ§¿Í Á¤ÀÇ
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¼ºÀå ¾ïÁ¦¿äÀÎ
±âȸ
°úÁ¦
ÁÖ¿ä µ¿Çâ
¼ºñ½º ¼ö¸íÁֱ⠺м®
³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå : ¹ë·ùüÀÎ
¿øÀç·á °ø±Þ¾÷ü ¸®½ºÆ®
Á¦Á¶¾÷ü ¸®½ºÆ®
ÆÇ¸Å´ë¸®Á¡ ¸®½ºÆ®
¾ÖÇø®ÄÉÀÌ¼Ç ¸®½ºÆ®
¼öÀͼº ºÐ¼®
Porter¡¯s Five Forces ºÐ¼®
ÁöÁ¤ÇÐÀû ±äÀå : ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ
°Å½Ã°æÁ¦Àû ¿äÀÎ
¼¼°èÀÇ ºÎ¹®º° Àü¸Á
¼¼°èÀÇ GDP ¼ºÀå·ü Àü¸Á
¼¼°èÀÇ »óºÎ ½ÃÀå °³¿ä
¿¹Ãø¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
±ÔÁ¦¿Í ±â¼ú »óȲ
Á¦3Àå ¼¼°èÀÇ ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå Àü¸Á : °ú°Å(2018-2022³â)¿Í ¿¹Ãø(2023-2030³â)
ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
½ÃÀå ¼ö·®(À¯´Ö) ¿¹Ãø
½ÃÀå ±Ô¸ð¿Í Àü³âºñ ¼ºÀå·ü
Àý´ëÀû ±Ý¾× ±âȸ
½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø
°ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®, 2013-2016³â
ÇöÀç ½ÃÀå ±Ô¸ð ¿¹Ãø, 2018-2026³â
¼¼°èÀÇ ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå Àü¸Á : ¼ºñ½º
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ºÐ¼® : ¼ºñ½ºº°, 2018-2022³â
ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø : ¼ºñ½ºº°, 2023-2030³â
ÀçÅà ³ëÀÎ ÄÉ¾î ¼ºñ½º
¼ºÀÎ ³ëÀÎ µ¥ÀÌÄÉ¾î ¼ºñ½º
½Ã¼³ ³ëÀÎ ÄÉ¾î ¼ºñ½º
½ÃÀå ¸Å·Â ºÐ¼® : ¼ºñ½º
¼¼°èÀÇ ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå Àü¸Á : ÁöºÒ¿ø
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ºÐ¼® : ÁöºÒ¿øº°, 2018-2022³â
ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø : ÁöºÒ¿øº°, 2023-2030³â
°øÀû º¸Çè¿¡ ÀÇÇÑ ÁöºÒ
¹Î°£ º¸Çè¿¡ ÀÇÇÑ ÁöºÒ
º»Àκδã±Ý
±âŸ ÁöºÒ
½ÃÀå ¸Å·Â ºÐ¼® : ÁöºÒ¿ø
¼¼°èÀÇ ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå Àü¸Á : ¿ëµµ
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ºÐ¼® : ¿ëµµº°, 2018-2022³â
ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø : ¿ëµµº°, 2023-2030³â
È£Èí±âÁúȯ
´ç´¢º´
½ÉÀåÁúȯ
½Å°æÁúȯ
½ÅÀåÁúȯ
¾Ï
±âŸ
½ÃÀå ¸Å·Â ºÐ¼® : ¿ëµµ
Á¦4Àå ¼¼°èÀÇ ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå Àü¸Á : Áö¿ª
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ºÐ¼® : Áö¿ªº°, 2018-2022³â
ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)¿Í ¼ö·®(´ÜÀ§) ¿¹Ãø : Áö¿ªº°, 2023-2030³â
ºÏ¹Ì
À¯·´
µ¿¾Æ½Ã¾Æ
³²¾Æ½Ã¾Æ¿Í ¿À¼¼¾Æ´Ï¾Æ
¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ª
Á¦5Àå ºÏ¹ÌÀÇ ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå Àü¸Á : °ú°Å(2018-2022³â)¿Í ¿¹Ãø(2023-2030³â)
Á¦6Àå À¯·´ÀÇ ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå Àü¸Á : °ú°Å(2018-2022³â)¿Í ¿¹Ãø(2023-2030³â)
Á¦7Àå µ¿¾Æ½Ã¾ÆÀÇ ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå Àü¸Á : °ú°Å(2018-2022³â)¿Í ¿¹Ãø(2023-2030³â)
Á¦8Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå Àü¸Á : °ú°Å(2018-2022³â)¿Í ¿¹Ãø(2023-2030³â)
Á¦9Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå Àü¸Á : °ú°Å(2018-2022³â)¿Í ¿¹Ãø(2023-2030³â)
Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ³ëÀÎ ÄÉ¾î ¼ºñ½º ½ÃÀå Àü¸Á : °ú°Å(2018-2022³â)¿Í ¿¹Ãø(2023-2030³â)
Á¦11Àå °æÀï »óȲ
½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â
½ÃÀå ±¸Á¶
±â¾÷ °³¿ä
Endo Pharmaceuticals Inc.
Merck & Co. Inc.
AstraZeneca PLC
Pfizer Inc.
Allergan Inc.
Bristol-Myers Squibb Company
Regeneron Pharmaceuticals Inc.
AstraZeneca PLC
F. Hoffmann-La Roche AG
Octapharma AG
Epoch Elder Care
St Luke's ElderCare Ltd.
Á¦12Àå ºÎ·Ï
ksm
¿µ¹® ¸ñÂ÷
Persistence Market Research has recently published an in-depth analysis of the global Geriatric Care Services Market, offering a comprehensive overview of key market dynamics, growth drivers, challenges, and emerging trends. This report provides valuable insights into the structure of the Geriatric Care Services Market, presenting exclusive data and statistics that forecast the market's growth trajectory from 2023 to 2030.
The worldwide market for geriatric care services is anticipated to grow steadily at a compound annual growth rate (CAGR) of 5.7%, reaching an estimated value of US$800.7 million in 2023 and projecting to surge to US$543.2 million by the conclusion of 2030.
Key Insights:
Geriatric Care Services Market Size (2023E): US$800.7 Mn
Projected Market Value (2030F): US$543.2 Mn
Global Market Growth Rate (CAGR 2023 to 2030): 5.7%
Historical Market Growth Rate (CAGR 2018 to 2022): 5.3%
Geriatric Care Services Market- Report Scope:
Geriatrics, or geriatric medicine, focuses on enhancing the well-being of older individuals by addressing age-related health issues. Geriatric care includes medical and non-medical services delivered in various settings such as homes, hospitals, and nursing homes. Examples include physical therapy and IV therapy. The market for geriatric care services is expected to grow due to increased R&D investment and favorable reimbursement policies, with a focus on improving offerings in the healthcare sector.
Market Growth Drivers:
The global demand for skilled nursing care services is experiencing a notable surge due to the increasing prevalence of Alzheimer's disease and dementia, which are common among the growing geriatric population worldwide. According to the World Health Organization (WHO), approximately 47.5 million people suffer from dementia globally, with 7.7 million new cases reported annually. Research indicates that lifestyle-related conditions such as diabetes, stroke, and high blood pressure contribute to the rising incidence of Alzheimer's, thereby propelling the market for skilled nursing care services. However, challenges such as high costs and limited acceptance hinder market growth. The continuous increase in the geriatric population places growing financial demands on healthcare systems, as highlighted by the WHO's forecast that the population aged 65 and above will nearly triple by 2050, particularly in developing nations. This demographic shift is expected to lead to a higher demand for geriatric care services, ultimately driving market growth.
Market Restraints:
The growth of the geriatric care services market faces significant challenges, notably the lack of geriatric care centers in rural areas. Elderly individuals in rural regions encounter limited access to tailored health services due to socioeconomic disparities and the absence of specialized facilities. Additionally, workforce shortages across various healthcare roles and increasing healthcare costs present immediate obstacles. The scarcity of qualified professionals and financial barriers hinder access to essential geriatric care services, emphasizing the need for strategic interventions to address these constraints and ensure equitable access to care for all elderly individuals.
Market Opportunities:
The growing awareness of elderly care presents significant opportunities for the global geriatric care services market. Recent shifts in healthcare management and the increasing prevalence of chronic diseases among the elderly have fueled market expansion. Governments are actively striving to enhance the quality of life for the aging population, driving demand for specialized elderly care services. Improved medical reimbursement policies and efforts to establish higher treatment standards further contribute to market growth. Anticipated increased investments in healthcare are expected to drive substantial revenue growth in the global geriatric care services market.
Key Questions Answered in the Report:
What are the key factors driving the growth of the Geriatric Care Services Market?
Which industry verticals are driving the demand for Geriatric Care Services?
How are technological advancements reshaping the competitive landscape of the Geriatric Care Services Market?
Who are the leading players in the global Geriatric Care Services Market?
What are the emerging trends and future prospects in the global Geriatric Care Services Market?
Competitive Intelligence and Business Strategy:
Leading organizations such as Endo Pharmaceuticals Inc., Merck & Co. Inc., and AstraZeneca PLC are driving innovation in the geriatric care sector, leveraging their technological expertise and extensive healthcare industry experience. Initiatives aimed at raising awareness and reducing hospital admissions among the elderly are widespread. Companies prioritize technological advancements, strategic partnerships, and improving user experience. Expansion into new markets through collaboration initiatives is a key focus, with a strong emphasis on differentiation through innovative features, personalized services, and value-added offerings to maintain competitiveness in the market.
Key Companies Profiled:
Endo Pharmaceuticals Inc.
Merck & Co. Inc.
AstraZeneca PLC
Pfizer Inc.
Allergan Inc.
Bristol-Myers Squibb Company
Regeneron Pharmaceuticals Inc.
AstraZeneca PLC
F. Hoffmann-La Roche AG
Octapharma AG
Epoch Elder Care
St Luke's ElderCare Ltd.
Geriatric Care Services Market Segmentation:
By Service:
Home Geriatric Care Services
Adult Geriatric Day Care Service
Institutional Geriatric Care Services
By Payment Source:
Payment via Public Insurance
Payment via Private Insurance
Out-of-Pocket Payment
Payment via Other Sources
By Application:
Respiratory Diseases
Diabetes
Heart Diseases
Neurological Diseases
Kidney Diseases
Cancer
Other
By Region:
North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa
Table of Contents
1. Executive Summary
1.1. Global Geriatric Care Services Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Services Lifecycle Analysis
2.4. Geriatric Care Services Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Geriatric Care Services Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Geriatric Care Services Market Outlook: Services
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Services, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Services, 2023 - 2030
3.3.3.1. Home Geriatric Care Services
3.3.3.2. Adult Geriatric Day Care Service
3.3.3.3. Institutional Geriatric Care Services
3.4. Market Attractiveness Analysis: Services
3.5. Global Geriatric Care Services Market Outlook: Payment Source
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Payment Source, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Payment Source, 2023 - 2030
3.5.3.1. Payment via Public Insurance
3.5.3.2. Payment via Private Insurance
3.5.3.3. Out-of-Pocket Payment
3.5.3.4. Payment via Other Sources
3.6. Market Attractiveness Analysis: Payment Source
3.7. Global Geriatric Care Services Market Outlook: Application
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
3.7.3.1. Respiratory Diseases
3.7.3.2. Diabetes
3.7.3.3. Heart Diseases
3.7.3.4. Neurological Diseases
3.7.3.5. Kidney Diseases
3.7.3.6. Cancer
3.7.3.7. Other
3.8. Market Attractiveness Analysis: Application
4. Global Geriatric Care Services Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Geriatric Care Services Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Services
5.3.3. By Payment Source
5.3.4. By Application
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Services, 2023 - 2030
5.5.1. Home Geriatric Care Services
5.5.2. Adult Geriatric Day Care Service
5.5.3. Institutional Geriatric Care Services
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Payment Source, 2023 - 2030
5.6.1. Payment via Public Insurance
5.6.2. Payment via Private Insurance
5.6.3. Out-of-Pocket Payment
5.6.4. Payment via Other Sources
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
5.7.1. Respiratory Diseases
5.7.2. Diabetes
5.7.3. Heart Diseases
5.7.4. Neurological Diseases
5.7.5. Kidney Diseases
5.7.6. Cancer
5.7.7. Other
5.8. Market Attractiveness Analysis
6. Europe Geriatric Care Services Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Services
6.3.3. By Payment Source
6.3.4. By Application
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Services, 2023 - 2030
6.5.1. Home Geriatric Care Services
6.5.2. Adult Geriatric Day Care Service
6.5.3. Institutional Geriatric Care Services
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Payment Source, 2023 - 2030
6.6.1. Payment via Public Insurance
6.6.2. Payment via Private Insurance
6.6.3. Out-of-Pocket Payment
6.6.4. Payment via Other Sources
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
6.7.1. Respiratory Diseases
6.7.2. Diabetes
6.7.3. Heart Diseases
6.7.4. Neurological Diseases
6.7.5. Kidney Diseases
6.7.6. Cancer
6.7.7. Other
6.8. Market Attractiveness Analysis
7. East Asia Geriatric Care Services Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Services
7.3.3. By Payment Source
7.3.4. By Application
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Services, 2023 - 2030
7.5.1. Home Geriatric Care Services
7.5.2. Adult Geriatric Day Care Service
7.5.3. Institutional Geriatric Care Services
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Payment Source, 2023 - 2030
7.6.1. Payment via Public Insurance
7.6.2. Payment via Private Insurance
7.6.3. Out-of-Pocket Payment
7.6.4. Payment via Other Sources
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
7.7.1. Respiratory Diseases
7.7.2. Diabetes
7.7.3. Heart Diseases
7.7.4. Neurological Diseases
7.7.5. Kidney Diseases
7.7.6. Cancer
7.7.7. Other
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Geriatric Care Services Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Services
8.3.3. By Payment Source
8.3.4. By Application
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Services, 2023 - 2030
8.5.1. Home Geriatric Care Services
8.5.2. Adult Geriatric Day Care Service
8.5.3. Institutional Geriatric Care Services
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Payment Source, 2023 - 2030
8.6.1. Payment via Public Insurance
8.6.2. Payment via Private Insurance
8.6.3. Out-of-Pocket Payment
8.6.4. Payment via Other Sources
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
8.7.1. Respiratory Diseases
8.7.2. Diabetes
8.7.3. Heart Diseases
8.7.4. Neurological Diseases
8.7.5. Kidney Diseases
8.7.6. Cancer
8.7.7. Other
8.8. Market Attractiveness Analysis
9. Latin America Geriatric Care Services Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Services
9.3.3. By Payment Source
9.3.4. By Application
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Services, 2023 - 2030
9.5.1. Home Geriatric Care Services
9.5.2. Adult Geriatric Day Care Service
9.5.3. Institutional Geriatric Care Services
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Payment Source, 2023 - 2030
9.6.1. Payment via Public Insurance
9.6.2. Payment via Private Insurance
9.6.3. Out-of-Pocket Payment
9.6.4. Payment via Other Sources
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
9.7.1. Respiratory Diseases
9.7.2. Diabetes
9.7.3. Heart Diseases
9.7.4. Neurological Diseases
9.7.5. Kidney Diseases
9.7.6. Cancer
9.7.7. Other
9.8. Market Attractiveness Analysis
10. Middle East & Africa Geriatric Care Services Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Services
10.3.3. By Payment Source
10.3.4. By Application
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Services, 2023 - 2030
10.5.1. Home Geriatric Care Services
10.5.2. Adult Geriatric Day Care Service
10.5.3. Institutional Geriatric Care Services
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Payment Source, 2023 - 2030
10.6.1. Payment via Public Insurance
10.6.2. Payment via Private Insurance
10.6.3. Out-of-Pocket Payment
10.6.4. Payment via Other Sources
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
10.7.1. Respiratory Diseases
10.7.2. Diabetes
10.7.3. Heart Diseases
10.7.4. Neurological Diseases
10.7.5. Kidney Diseases
10.7.6. Cancer
10.7.7. Other
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Endo Pharmaceuticals Inc.
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Merck & Co. Inc.
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. AstraZeneca PLC
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Pfizer Inc.
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Allergan Inc.
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Bristol-Myers Squibb Company
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Regeneron Pharmaceuticals Inc.
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. AstraZeneca PLC
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. F. Hoffmann-La Roche AG
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Octapharma AG
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Epoch Elder Care
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
11.3.12. St Luke's ElderCare Ltd.
11.3.12.1. Overview
11.3.12.2. Segments and Product
11.3.12.3. Key Financials
11.3.12.4. Market Developments
11.3.12.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
°ü·ÃÀÚ·á